ArticlePharmaceutics2023

A Novel and Highly Selective Epidermal Growth Factor Receptor Inhibitor, SMUZ106, for the Treatment of Glioblastoma.

Ying Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.